Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 6

eBook: US $69 Special Offer (PDF + Printed Copy): US $117
Printed Copy: US $83
Library License: US $276
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-981-14-7917-5 (Print)
ISBN: 978-981-14-7919-9 (Online)
Year of Publication: 2021
DOI: 10.2174/97816810875351200601


Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The sixth volume of this series features 6 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist.

  • - The failing heart in diabetes with special emphasis on prevention
  • - Flavonoids as prominent anti-diabetic agents
  • - Chemosensor in glucose monitoring, advances and challenges
  • - Synergistic drugs and polyherbal formulations for obesity: current status and future prospectives
  • - Urge for herbal anti-diabetic medicines towards clinical and therapeutic implications
  • - Curcuma longa as dietary supplement and diabetes mellitus: evidence from experimental studies


Pharmaceutical Scientists, Medicinal Chemists, Internal medicine specialists, endocrinologists, diabetologists, medical professionals


The sixth volume of Frontiers in Clinical Drug Research – Diabetes and Obesity comprises six comprehensive chapters that present novel approaches to combat diabetes and obesity.

Roy and Khalse summarize the current state of knowledge on the epidemiology, interrelationships of heart failure and type 2 diabetes. The review covers the pathophysiology, clinical correlates, and the current status of emerging novel therapies in the field.

Flavonoids are naturally occurring compounds which make them attractive candidates to study anti-diabetic medicines. Rammohan and Bhaskar in chapter 2 of the book emphasize the importance and therapeutic potential of flavonoids as templates for future diabetic therapeutic drugs. . In the next chapter, techniques for combining biological sensing and fluorescent nanomaterials components are explored, and the applicability of chemosensors for glucose testing is discussed .

Chapter 4 of the book summarizes the current status and prospects of synergistic drugs and polyherbal formulations in the development of safe and functional drugs for the management of obesity. In next chapter of the book, a detailed and in-depth analysis of herbal antidiabetic drugs and various commonly used anti-diabetic plants are discussed.

In last chapter of the book, Sarfraz et al., discuss turmeric’s (Curcuma longa) potential for treatment of diabetes mellitus and the hypoglycemic, antioxidant, and anti-inflammatory qualities of its chemical constituents.

I owe special thanks to all the contributors for their valuable contributions in bringing together the sixth volume of this book series. I am also thankful to the efficient team of Bentham Science Publishers for the timely efforts made by the editorial personnel, especially Mr. Mahmood Alam (Editorial Director), Mr. Obaid Sadiq (in-charge Books Department) and Ms. Asma Ahmed (Manager Publications).

Atta-ur-Rahman, FRS
Kings College
University of Cambridge


.Nanoscience Applications in Diabetes Treatment.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Diabesity: A Multidisciplinary Approach.
.Pharmacological and Molecular Perspectives on Diabetes.